Zachariah M. DeFilipp, MD, Massachusetts General Hospital
Advertisement
Articles by Zachariah M. DeFilipp, MD, Massachusetts General Hospital
Advertisement
Latest Updated Articles
Risk Factors for Graft-vs-Host DiseasePublished: June 19th 2020 | Updated:
Risk Factors, Incidence & Typical Presentation of GvHDPublished: June 11th 2020 | Updated:
Treatment for Steroid-Refractory GVHD: REACH2Published: June 11th 2020 | Updated:
Special Transplant SituationsPublished: June 19th 2020 | Updated:
GvHD Management RecommendationsPublished: June 11th 2020 | Updated:
Members of the Transplant TeamPublished: June 19th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma
5